Evaluating new contraceptive methods for men and women
Official title: STATUS DETERMINATION AND PRIORITIZATION OF PIPELINE PRODUCTS UNDERGOING CLINICAL TRIALS FOR MALE AND FEMALE CONTRACEPTION
Funded at Health Decisions, INC. · NIH-11063765 · Data updated 2026-11-12
This study is looking for people to help test new and safe birth control methods for both men and women, with the hope of creating better options for everyone.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Health Decisions, INC. NIH-funded |
| Lab location | 1 site (Morrisville, United States) |
| Project start | September 24, 2019 |
| Project end | September 30, 2025 |
| Funding year | 2024 |
| Award (this year) | $249,222 |
| NIH project number | 75N94019D00004-P00002-759401900126-1 |
| Project ID | NIH-11063765 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation are individuals seeking new contraceptive options, including both men and women of reproductive age.
✕Less likely to help
Patients who are not interested in contraception or those who have contraindications to participating in clinical trials may not benefit from this research.
What this research studies
This research focuses on the development and evaluation of safe and effective contraceptive methods for both men and women. It involves coordinating clinical trials at pre-qualified sites to assess new contraceptive products. The study includes comprehensive data collection, analysis, and regulatory review to determine the status and prioritization of these products in the developmental pipeline. Patients may have the opportunity to participate in trials that could lead to innovative contraceptive options.
Why it matters
Potential benefit: If successful, this research could lead to the introduction of new contraceptive methods that are safer and more effective for patients.
How similar studies have gone: Previous research in contraceptive development has shown promise, indicating that innovative approaches can lead to successful new products.
Where this research is happening
-
Health Decisions, INC.
Morrisville, United States Active
Researchers
- Principal investigator: Dart, Clint — Health Decisions, INC.
- Study coordinator: Dart, Clint
Related research
Other NIH-funded projects on the same topics.
-
Mobile health support to boost PrEP and contraception use among young women in Zambia
A mobile health program helps female university students in Zambia learn about and access HIV prevention and contraception.
-
A woman-controlled, nonhormonal on-demand contraceptive device
This project is creating a woman-controlled vaginal device that releases a fabric-like polymer which thickens on contact with semen to help prevent pregnancy.
-
Mobile health tool to boost PrEP and contraception use among female university students in Zambia
A mobile, peer-supported program helps young women in Zambia start and stick with PrEP and modern contraception to prevent HIV and unintended pregnancy.
-
Evaluating a new injectable contraceptive for women
This study is testing a new long-lasting birth control shot called levonorgestrel butanoate, especially for women who are overweight and at risk for blood clots, to see if it works well and is safe without the added hormones found in other methods.
-
Evaluating a new injectable contraceptive for women
This study is testing a new long-lasting birth control shot called levonorgestrel butanoate, especially for women who are obese and may be at risk for blood clots, to see if it can be a safer and easier option without the hormones found in many other contraceptives.
-
Evaluating a new injectable contraceptive for women
This study is testing a new long-lasting birth control shot called levonorgestrel butanoate, which is made for women, especially those who are overweight and may have a higher risk of blood clots, to see how well it works and how it moves through the body, while offering a safer and easier option than taking a pill eve
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.